
NATURE . COM {
}
Title:
IGF-1R inhibition induces MEK phosphorylation to promote survival in colon carcinomas | Signal Transduction and Targeted Therapy
Description:
The insulin-like growth factor 1 receptor (IGF-1R) governs several signaling pathways for cell proliferation, survival, and anti-apoptosis. Thus, targeting IGF-1R appears as a reasonable rationale for tumor treatment. However, clinical studies showed that inhibition of IGF-1R has very limited efficacy due to the development of resistance to IGF-1R blockade in tumor cells. Here, we discovered that prolonged treatment of colon cancer cells with IGF-1R inhibitors (BMS-754807 and GSK1838705A) stimulates p70 KDa ribosomal protein S6 kinase 1 (p70S6K1) activation, a well-known kinase signaling for cell survival. We also found that p70S6K1 activation by IGF-1R inhibition is independent of K-Ras and PIK3CA mutations that frequently occur in colon cancer. Besides the increased p70S6K1 phosphorylation, the phosphorylation of mitogen-activated protein kinase kinase 1 and 2 (MEK1/2) was elevated in the cells treated with BMS-754807. Interestingly, the increases in MEK1/2 and p70S6K1 phosphorylation were also observed when cells were subjected to the treatment of AKT inhibitor or genetic knockdown of AKT2 but not AKT1, suggesting that AKT2 inhibition stimulates MEK1/2 phosphorylation to activate p70S6K1. Conversely, inhibition of MEK1/2 by MEK1/2 inhibitor (U0126) or knockdown of MEK1 and MEK2 by corresponding mek1 and mek2 siRNA enhanced AKT phosphorylation, indicating mutual inhibition between AKT and MEK. Furthermore, the combination of BMS-754807 and U0126 efficiently decreased the cell viability and increased cleaved caspase 3 and apoptosis in vitro and in vivo. Our data suggest that the treatment of colon tumor cells with IGF-1R inhibitors stimulates p70S6K1 activity via MEK1/2 to promote survival, providing a new strategy for colorectal cancer therapeutics.
Website Age:
30 years and 10 months (reg. 1994-08-11).
Matching Content Categories {📚}
- Science
- Education
- Health & Fitness
Content Management System {📝}
What CMS is nature.com built with?
Custom-built
No common CMS systems were detected on Nature.com, and no known web development framework was identified.
Traffic Estimate {📈}
What is the average monthly size of nature.com audience?
🌆 Monumental Traffic: 20M - 50M visitors per month
Based on our best estimate, this website will receive around 42,554,915 visitors per month in the current month.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Nature.com Make Money? {💸}
Display Ads {🎯}
The website utilizes display ads within its content to generate revenue. Check the next section for further revenue estimates.
Ads are managed by yourbow.com. Particular relationships are as follows:
Direct Advertisers (10)
google.com, pmc.com, doceree.com, yourbow.com, audienciad.com, onlinemediasolutions.com, advibe.media, aps.amazon.com, getmediamx.com, onomagic.comReseller Advertisers (38)
conversantmedia.com, rubiconproject.com, pubmatic.com, appnexus.com, openx.com, smartadserver.com, lijit.com, sharethrough.com, video.unrulymedia.com, google.com, yahoo.com, triplelift.com, onetag.com, sonobi.com, contextweb.com, 33across.com, indexexchange.com, media.net, themediagrid.com, adform.com, richaudience.com, sovrn.com, improvedigital.com, freewheel.tv, smaato.com, yieldmo.com, amxrtb.com, adyoulike.com, adpone.com, criteo.com, smilewanted.com, 152media.info, e-planning.net, smartyads.com, loopme.com, opera.com, mediafuse.com, betweendigital.comHow Much Does Nature.com Make? {💰}
Display Ads {🎯}
$536,300 per month
According to our algorithms, Nature.com's monthly online income from display advertising ranges from $357,503 to $983,134.
Keywords {🔍}
psk, cells, phosphorylation, bms, mek, igfr, akt, fig, inhibition, cell, treated, pubmed, cancer, pdcd, activation, google, scholar, inhibitor, tumor, cas, colon, translation, data, protein, treatment, increased, knockdown, shown, hct, growth, survival, activity, mice, osi, analyzed, mrna, kinase, erk, significantly, western, central, resistance, independent, nature, levels, blot, images, induces, proliferation, inhibitors,
Topics {✒️}
nature portfolio privacy policy nature advertising social media dual igf-ir/ir inhibitor a-raf-related protein phosphorylation reprints p70 s6-kinase mediates igf-1r-mediated activation real-time quantitative pcr igf-1r governs pi3k/akt igf-1r signaling pathway targeting igf-1r appears artificial stem-loop structure hsin-sheng yang overcoming igf1r/ir resistance potent igf-1r inhibitor igf-1r/ir inhibitor full size image igf-ir null cells growth factor-1r/ir anti-igf-1r agents represses p53-dependent apoptosis phospho-s6 ribosomal protein antibodies targeting igf-1r markey cancer center author correspondence original author permissions phospho-p-70s6k1/gapdh igf-1r expression levels colon cancer therapy ras/erk signaling pathways ribosome-bound rnas igf-1r inhibition results inhibits pro-apoptotic proteins stress-induced kinases inhibits p53-dependent apoptosis pathogen-free conditions bms-754807-induced p70s6k1 activation dead box helicases kras mutation testing krasg12c inhibitors mediated china authors china academy development promotes cell death pro-apoptotic molecule bad ribosomal protein s6
Questions {❓}
- How does MEK activate AKT?
- If it is through IGF-1R inhibition, what is the molecular mechanism to induce p70S6K1 activation?
Schema {🗺️}
WebPage:
mainEntity:
headline:IGF-1R inhibition induces MEK phosphorylation to promote survival in colon carcinomas
description:The insulin-like growth factor 1 receptor (IGF-1R) governs several signaling pathways for cell proliferation, survival, and anti-apoptosis. Thus, targeting IGF-1R appears as a reasonable rationale for tumor treatment. However, clinical studies showed that inhibition of IGF-1R has very limited efficacy due to the development of resistance to IGF-1R blockade in tumor cells. Here, we discovered that prolonged treatment of colon cancer cells with IGF-1R inhibitors (BMS-754807 and GSK1838705A) stimulates p70 KDa ribosomal protein S6 kinase 1 (p70S6K1) activation, a well-known kinase signaling for cell survival. We also found that p70S6K1 activation by IGF-1R inhibition is independent of K-Ras and PIK3CA mutations that frequently occur in colon cancer. Besides the increased p70S6K1 phosphorylation, the phosphorylation of mitogen-activated protein kinase kinase 1 and 2 (MEK1/2) was elevated in the cells treated with BMS-754807. Interestingly, the increases in MEK1/2 and p70S6K1 phosphorylation were also observed when cells were subjected to the treatment of AKT inhibitor or genetic knockdown of AKT2 but not AKT1, suggesting that AKT2 inhibition stimulates MEK1/2 phosphorylation to activate p70S6K1. Conversely, inhibition of MEK1/2 by MEK1/2 inhibitor (U0126) or knockdown of MEK1 and MEK2 by corresponding mek1 and mek2 siRNA enhanced AKT phosphorylation, indicating mutual inhibition between AKT and MEK. Furthermore, the combination of BMS-754807 and U0126 efficiently decreased the cell viability and increased cleaved caspase 3 and apoptosis in vitro and in vivo. Our data suggest that the treatment of colon tumor cells with IGF-1R inhibitors stimulates p70S6K1 activity via MEK1/2 to promote survival, providing a new strategy for colorectal cancer therapeutics.
datePublished:2020-08-26T00:00:00Z
dateModified:2020-08-26T00:00:00Z
pageStart:1
pageEnd:11
license:http://creativecommons.org/licenses/by/4.0/
sameAs:https://doi.org/10.1038/s41392-020-0204-0
keywords:
Cancer therapy
Gastrointestinal cancer
Medicine/Public Health
general
Internal Medicine
Cancer Research
Cell Biology
Pathology
Oncology
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41392-020-0204-0/MediaObjects/41392_2020_204_Fig1_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41392-020-0204-0/MediaObjects/41392_2020_204_Fig2_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41392-020-0204-0/MediaObjects/41392_2020_204_Fig3_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41392-020-0204-0/MediaObjects/41392_2020_204_Fig4_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41392-020-0204-0/MediaObjects/41392_2020_204_Fig5_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41392-020-0204-0/MediaObjects/41392_2020_204_Fig6_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41392-020-0204-0/MediaObjects/41392_2020_204_Fig7_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41392-020-0204-0/MediaObjects/41392_2020_204_Fig8_HTML.png
isPartOf:
name:Signal Transduction and Targeted Therapy
issn:
2059-3635
volumeNumber:5
type:
Periodical
PublicationVolume
publisher:
name:Nature Publishing Group UK
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Qing Wang
affiliation:
name:University of Kentucky
address:
name:Department of Toxicology and Cancer Biology, College of Medicine, University of Kentucky, Lexington, USA
type:PostalAddress
type:Organization
type:Person
name:Yan Zhang
affiliation:
name:University of Kentucky
address:
name:Department of Toxicology and Cancer Biology, College of Medicine, University of Kentucky, Lexington, USA
type:PostalAddress
type:Organization
type:Person
name:Jiang Zhu
affiliation:
name:University of Kentucky
address:
name:Department of Toxicology and Cancer Biology, College of Medicine, University of Kentucky, Lexington, USA
type:PostalAddress
type:Organization
name:Qilu Hospital of Shandong University
address:
name:Department of Breast Surgery, Qilu Hospital of Shandong University, Jinan, China
type:PostalAddress
type:Organization
name:Qilu Hospital of Shandong University
address:
name:Department of Breast Surgery, Qilu Hospital of Shandong University, Jinan, China
type:PostalAddress
type:Organization
type:Person
name:Honggang Zheng
affiliation:
name:China Academy of Chinese Medical Sciences
address:
name:Department of Oncology, Guangâanmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China
type:PostalAddress
type:Organization
type:Person
name:Shuntai Chen
affiliation:
name:China Academy of Chinese Medical Sciences
address:
name:Department of Oncology, Guangâanmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China
type:PostalAddress
type:Organization
type:Person
name:Li Chen
affiliation:
name:University of Kentucky
address:
name:Markey Cancer Center, College of Medicine, University of Kentucky, Lexington, USA
type:PostalAddress
type:Organization
type:Person
name:Hsin-Sheng Yang
affiliation:
name:University of Kentucky
address:
name:Department of Toxicology and Cancer Biology, College of Medicine, University of Kentucky, Lexington, USA
type:PostalAddress
type:Organization
name:University of Kentucky
address:
name:Markey Cancer Center, College of Medicine, University of Kentucky, Lexington, USA
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:1
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:IGF-1R inhibition induces MEK phosphorylation to promote survival in colon carcinomas
description:The insulin-like growth factor 1 receptor (IGF-1R) governs several signaling pathways for cell proliferation, survival, and anti-apoptosis. Thus, targeting IGF-1R appears as a reasonable rationale for tumor treatment. However, clinical studies showed that inhibition of IGF-1R has very limited efficacy due to the development of resistance to IGF-1R blockade in tumor cells. Here, we discovered that prolonged treatment of colon cancer cells with IGF-1R inhibitors (BMS-754807 and GSK1838705A) stimulates p70 KDa ribosomal protein S6 kinase 1 (p70S6K1) activation, a well-known kinase signaling for cell survival. We also found that p70S6K1 activation by IGF-1R inhibition is independent of K-Ras and PIK3CA mutations that frequently occur in colon cancer. Besides the increased p70S6K1 phosphorylation, the phosphorylation of mitogen-activated protein kinase kinase 1 and 2 (MEK1/2) was elevated in the cells treated with BMS-754807. Interestingly, the increases in MEK1/2 and p70S6K1 phosphorylation were also observed when cells were subjected to the treatment of AKT inhibitor or genetic knockdown of AKT2 but not AKT1, suggesting that AKT2 inhibition stimulates MEK1/2 phosphorylation to activate p70S6K1. Conversely, inhibition of MEK1/2 by MEK1/2 inhibitor (U0126) or knockdown of MEK1 and MEK2 by corresponding mek1 and mek2 siRNA enhanced AKT phosphorylation, indicating mutual inhibition between AKT and MEK. Furthermore, the combination of BMS-754807 and U0126 efficiently decreased the cell viability and increased cleaved caspase 3 and apoptosis in vitro and in vivo. Our data suggest that the treatment of colon tumor cells with IGF-1R inhibitors stimulates p70S6K1 activity via MEK1/2 to promote survival, providing a new strategy for colorectal cancer therapeutics.
datePublished:2020-08-26T00:00:00Z
dateModified:2020-08-26T00:00:00Z
pageStart:1
pageEnd:11
license:http://creativecommons.org/licenses/by/4.0/
sameAs:https://doi.org/10.1038/s41392-020-0204-0
keywords:
Cancer therapy
Gastrointestinal cancer
Medicine/Public Health
general
Internal Medicine
Cancer Research
Cell Biology
Pathology
Oncology
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41392-020-0204-0/MediaObjects/41392_2020_204_Fig1_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41392-020-0204-0/MediaObjects/41392_2020_204_Fig2_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41392-020-0204-0/MediaObjects/41392_2020_204_Fig3_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41392-020-0204-0/MediaObjects/41392_2020_204_Fig4_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41392-020-0204-0/MediaObjects/41392_2020_204_Fig5_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41392-020-0204-0/MediaObjects/41392_2020_204_Fig6_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41392-020-0204-0/MediaObjects/41392_2020_204_Fig7_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41392-020-0204-0/MediaObjects/41392_2020_204_Fig8_HTML.png
isPartOf:
name:Signal Transduction and Targeted Therapy
issn:
2059-3635
volumeNumber:5
type:
Periodical
PublicationVolume
publisher:
name:Nature Publishing Group UK
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Qing Wang
affiliation:
name:University of Kentucky
address:
name:Department of Toxicology and Cancer Biology, College of Medicine, University of Kentucky, Lexington, USA
type:PostalAddress
type:Organization
type:Person
name:Yan Zhang
affiliation:
name:University of Kentucky
address:
name:Department of Toxicology and Cancer Biology, College of Medicine, University of Kentucky, Lexington, USA
type:PostalAddress
type:Organization
type:Person
name:Jiang Zhu
affiliation:
name:University of Kentucky
address:
name:Department of Toxicology and Cancer Biology, College of Medicine, University of Kentucky, Lexington, USA
type:PostalAddress
type:Organization
name:Qilu Hospital of Shandong University
address:
name:Department of Breast Surgery, Qilu Hospital of Shandong University, Jinan, China
type:PostalAddress
type:Organization
name:Qilu Hospital of Shandong University
address:
name:Department of Breast Surgery, Qilu Hospital of Shandong University, Jinan, China
type:PostalAddress
type:Organization
type:Person
name:Honggang Zheng
affiliation:
name:China Academy of Chinese Medical Sciences
address:
name:Department of Oncology, Guangâanmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China
type:PostalAddress
type:Organization
type:Person
name:Shuntai Chen
affiliation:
name:China Academy of Chinese Medical Sciences
address:
name:Department of Oncology, Guangâanmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China
type:PostalAddress
type:Organization
type:Person
name:Li Chen
affiliation:
name:University of Kentucky
address:
name:Markey Cancer Center, College of Medicine, University of Kentucky, Lexington, USA
type:PostalAddress
type:Organization
type:Person
name:Hsin-Sheng Yang
affiliation:
name:University of Kentucky
address:
name:Department of Toxicology and Cancer Biology, College of Medicine, University of Kentucky, Lexington, USA
type:PostalAddress
type:Organization
name:University of Kentucky
address:
name:Markey Cancer Center, College of Medicine, University of Kentucky, Lexington, USA
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:1
["Periodical","PublicationVolume"]:
name:Signal Transduction and Targeted Therapy
issn:
2059-3635
volumeNumber:5
Organization:
name:Nature Publishing Group UK
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:University of Kentucky
address:
name:Department of Toxicology and Cancer Biology, College of Medicine, University of Kentucky, Lexington, USA
type:PostalAddress
name:University of Kentucky
address:
name:Department of Toxicology and Cancer Biology, College of Medicine, University of Kentucky, Lexington, USA
type:PostalAddress
name:University of Kentucky
address:
name:Department of Toxicology and Cancer Biology, College of Medicine, University of Kentucky, Lexington, USA
type:PostalAddress
name:Qilu Hospital of Shandong University
address:
name:Department of Breast Surgery, Qilu Hospital of Shandong University, Jinan, China
type:PostalAddress
name:Qilu Hospital of Shandong University
address:
name:Department of Breast Surgery, Qilu Hospital of Shandong University, Jinan, China
type:PostalAddress
name:China Academy of Chinese Medical Sciences
address:
name:Department of Oncology, Guangâanmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China
type:PostalAddress
name:China Academy of Chinese Medical Sciences
address:
name:Department of Oncology, Guangâanmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China
type:PostalAddress
name:University of Kentucky
address:
name:Markey Cancer Center, College of Medicine, University of Kentucky, Lexington, USA
type:PostalAddress
name:University of Kentucky
address:
name:Department of Toxicology and Cancer Biology, College of Medicine, University of Kentucky, Lexington, USA
type:PostalAddress
name:University of Kentucky
address:
name:Markey Cancer Center, College of Medicine, University of Kentucky, Lexington, USA
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:Qing Wang
affiliation:
name:University of Kentucky
address:
name:Department of Toxicology and Cancer Biology, College of Medicine, University of Kentucky, Lexington, USA
type:PostalAddress
type:Organization
name:Yan Zhang
affiliation:
name:University of Kentucky
address:
name:Department of Toxicology and Cancer Biology, College of Medicine, University of Kentucky, Lexington, USA
type:PostalAddress
type:Organization
name:Jiang Zhu
affiliation:
name:University of Kentucky
address:
name:Department of Toxicology and Cancer Biology, College of Medicine, University of Kentucky, Lexington, USA
type:PostalAddress
type:Organization
name:Qilu Hospital of Shandong University
address:
name:Department of Breast Surgery, Qilu Hospital of Shandong University, Jinan, China
type:PostalAddress
type:Organization
name:Qilu Hospital of Shandong University
address:
name:Department of Breast Surgery, Qilu Hospital of Shandong University, Jinan, China
type:PostalAddress
type:Organization
name:Honggang Zheng
affiliation:
name:China Academy of Chinese Medical Sciences
address:
name:Department of Oncology, Guangâanmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China
type:PostalAddress
type:Organization
name:Shuntai Chen
affiliation:
name:China Academy of Chinese Medical Sciences
address:
name:Department of Oncology, Guangâanmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China
type:PostalAddress
type:Organization
name:Li Chen
affiliation:
name:University of Kentucky
address:
name:Markey Cancer Center, College of Medicine, University of Kentucky, Lexington, USA
type:PostalAddress
type:Organization
name:Hsin-Sheng Yang
affiliation:
name:University of Kentucky
address:
name:Department of Toxicology and Cancer Biology, College of Medicine, University of Kentucky, Lexington, USA
type:PostalAddress
type:Organization
name:University of Kentucky
address:
name:Markey Cancer Center, College of Medicine, University of Kentucky, Lexington, USA
type:PostalAddress
type:Organization
email:[email protected]
PostalAddress:
name:Department of Toxicology and Cancer Biology, College of Medicine, University of Kentucky, Lexington, USA
name:Department of Toxicology and Cancer Biology, College of Medicine, University of Kentucky, Lexington, USA
name:Department of Toxicology and Cancer Biology, College of Medicine, University of Kentucky, Lexington, USA
name:Department of Breast Surgery, Qilu Hospital of Shandong University, Jinan, China
name:Department of Breast Surgery, Qilu Hospital of Shandong University, Jinan, China
name:Department of Oncology, Guangâanmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China
name:Department of Oncology, Guangâanmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China
name:Markey Cancer Center, College of Medicine, University of Kentucky, Lexington, USA
name:Department of Toxicology and Cancer Biology, College of Medicine, University of Kentucky, Lexington, USA
name:Markey Cancer Center, College of Medicine, University of Kentucky, Lexington, USA
External Links {🔗}(127)
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19029956 generate?
- Learn how profitable http://scholar.google.com/scholar_lookup?&title=Insulin%20and%20insulin-like%20growth%20factor%20signalling%20in%20neoplasia&journal=Nat.%20Rev.%20Cancer&volume=8&pages=915-928&publication_year=2008&author=Pollak%2CM is on a monthly basis
- Profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=29285186
- What are the earnings of http://scholar.google.com/scholar_lookup?&title=Function%20of%20insulin-like%20growth%20factor%201%20receptor%20in%20cancer%20resistance%20to%20chemotherapy&journal=Oncol.%20Lett.&volume=15&pages=41-47&publication_year=2018&author=Yuan%2CJ&author=Yin%2CZ&author=Tao%2CK&author=Wang%2CG&author=Gao%2CJ?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9381178 net monthly?
- Profit of http://scholar.google.com/scholar_lookup?&title=Interleukin-3-induced%20phosphorylation%20of%20BAD%20through%20the%20protein%20kinase%20Akt&journal=Science&volume=278&pages=687-689&publication_year=1997&author=Peso%2CL&author=Gonzalez-Garcia%2CM&author=Page%2CC&author=Herrera%2CR&author=Nunez%2CG
- Discover the revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9812896
- What's the profit of http://scholar.google.com/scholar_lookup?&title=Regulation%20of%20cell%20death%20protease%20caspase-9%20by%20phosphorylation&journal=Science&volume=282&pages=1318-1321&publication_year=1998&author=Cardone%2CMH?
- What's http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12412161's gross income?
- Learn how profitable http://scholar.google.com/scholar_lookup?&title=Overexpression%20of%20the%20insulin-like%20growth%20factor%20I%20receptor%20in%20human%20colon%20carcinomas&journal=Cancer&volume=95&pages=2086-2095&publication_year=2002&author=Weber%2CMM is on a monthly basis
- What's the financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10534157?
- What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=Expression%20of%20insulin-like%20growth%20factor-1%20receptor%20in%20human%20colorectal%20cancer&journal=Hum.%20Pathol.&volume=30&pages=1128-1133&publication_year=1999&author=Hakam%2CA?
- How much cash flow does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=29843755 have monthly?
- What are the total earnings of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5975422?
- Earnings of http://scholar.google.com/scholar_lookup?&title=Randomized%2C%20phase%20I%2FII%20study%20of%20gemcitabine%20plus%20IGF-1R%20antagonist%20%28MK-0646%29%20versus%20gemcitabine%20plus%20erlotinib%20with%20and%20without%20MK-0646%20for%20advanced%20pancreatic%20adenocarcinoma&journal=J.%20Hematol.%20Oncol.&volume=11&publication_year=2018&author=Abdel-Wahab%2CR
- What's the financial gain of http://scholar.google.com/scholar_lookup?&title=A%20phase%202%20study%20of%20OSI-906%20%28linsitinib%2C%20an%20insulin-like%20growth%20factor%20receptor-1%20inhibitor%29%20in%20patients%20with%20asymptomatic%20or%20mildly%20symptomatic%20%28non-opioid%20requiring%29%20metastatic%20castrate%20resistant%20prostate%20cancer%20%28CRPC%29&journal=Investig.%20New%20Drugs&volume=36&pages=451-457&publication_year=2018&author=Barata%2CP?
- Income figures for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=28772281
- How profitable is http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5589984?
- See how much http://scholar.google.com/scholar_lookup?&title=Randomised%20Phase%202%20study%20of%20maintenance%20linsitinib%20%28OSI-906%29%20in%20combination%20with%20erlotinib%20compared%20with%20placebo%20plus%20erlotinib%20after%20platinum-based%20chemotherapy%20in%20patients%20with%20advanced%20non-small%20cell%20lung%20cancer&journal=Br.%20J.%20Cancer&volume=117&pages=757-766&publication_year=2017&author=Ciuleanu%2CTE makes per month
- How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25573956 make?
- Revenue of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4456303
- Profit of http://scholar.google.com/scholar_lookup?&title=Inhibition%20of%20p70S6K1%20activation%20by%20Pdcd4%20overcomes%20the%20resistance%20to%20an%20IGF-1R%2FIR%20inhibitor%20in%20colon%20carcinoma%20cells&journal=Mol.%20Cancer%20Ther.&volume=14&pages=799-809&publication_year=2015&author=Zhang%2CY&author=Wang%2CQ&author=Chen%2CL&author=Yang%2CHS
- Check the income stats for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20932932
- http://scholar.google.com/scholar_lookup?&title=Functions%20and%20regulation%20of%20the%2070kDa%20ribosomal%20S6%20kinases&journal=Int.%20J.%20Biochem.%20Cell%20Biol.&volume=43&pages=47-59&publication_year=2011&author=Fenton%2CTR&author=Gout%2CIT's total income per month
- What's the revenue for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12217521?
- Financial intake of http://scholar.google.com/scholar_lookup?&title=The%20PTEN%2C%20Mdm2%2C%20p53%20tumor%20suppressor-oncoprotein%20network&journal=Trends%20Biochem.%20Sci.&volume=27&pages=462-467&publication_year=2002&author=Mayo%2CLD&author=Donner%2CDB
- What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=The%20role%20of%20Pdcd4%20in%20tumour%20suppression%20and%20protein%20translation&journal=Biol.%20Cell&volume=110&pages=169-177&publication_year=2018&author=Wang%2CQ&author=Yang%2CHS?
- What are the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17849461?
- What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=Loss%20of%20programmed%20cell%20death%204%20expression%20marks%20adenoma-carcinoma%20transition%2C%20correlates%20inversely%20with%20phosphorylated%20protein%20kinase%20B%2C%20and%20is%20an%20independent%20prognostic%20factor%20in%20resected%20colorectal%20cancer&journal=Cancer&volume=110&pages=1697-1707&publication_year=2007&author=Mudduluru%2CG?
- Get to know what's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17828298
- Profit of http://scholar.google.com/scholar_lookup?&title=Downregulation%20of%20tumor%20suppressor%20Pdcd4%20promotes%20invasion%20and%20activates%20both%20beta-catenin%2FTcf%20and%20AP-1-dependent%20transcription%20in%20colon%20carcinoma%20cells&journal=Oncogene&volume=27&pages=1527-1535&publication_year=2008&author=Wang%2CQ&author=Sun%2CZ&author=Yang%2CHS
- Profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12482958
- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC140682's financial summary
- Get to know http://scholar.google.com/scholar_lookup?&title=The%20transformation%20suppressor%20Pdcd4%20is%20a%20novel%20eukaryotic%20translation%20initiation%20factor%204A%20binding%20protein%20that%20inhibits%20translation&journal=Mol.%20Cell.%20Biol.&volume=23&pages=26-37&publication_year=2003&author=Yang%2CHS's earnings
- Explore the financials of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12206455
- How much does http://scholar.google.com/scholar_lookup?&title=eIF4A%3A%20the%20godfather%20of%20the%20DEAD%20box%20helicases&journal=Prog.%20Nucleic%20Acid%20Res.%20Mol.%20Biol.&volume=72&pages=307-331&publication_year=2002&author=Rogers%2CGW&author=Komar%2CAA&author=Merrick%2CWC net monthly?
- What's the monthly money flow for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11333019?
- How much income does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1370095 have?
- Learn how profitable http://scholar.google.com/scholar_lookup?&title=The%20requirement%20for%20eukaryotic%20initiation%20factor%204A%20%28elF4A%29%20in%20translation%20is%20in%20direct%20proportion%20to%20the%20degree%20of%20mRNA%205%E2%80%99%20secondary%20structure&journal=RNA&volume=7&pages=382-394&publication_year=2001&author=Svitkin%2CYV is on a monthly basis
- How much cash flow does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=28692058 have monthly?
- How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5680133 pull in monthly?
- How much income is http://scholar.google.com/scholar_lookup?&title=Tumor%20suppressor%20Pdcd4%20attenuates%20Sin1%20translation%20to%20inhibit%20invasion%20in%20colon%20carcinoma&journal=Oncogene&volume=36&pages=6225-6234&publication_year=2017&author=Wang%2CQ earning monthly?
- Monthly income for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19996272
- What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=BMS-754807%2C%20a%20small%20molecule%20inhibitor%20of%20insulin-like%20growth%20factor-1R%2FIR&journal=Mol.%20Cancer%20Ther.&volume=8&pages=3341-3349&publication_year=2009&author=Carboni%2CJM?
- What's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20610571?
- How much income is http://scholar.google.com/scholar_lookup?&title=Insulin%20receptor%20%28IR%29%20pathway%20hyperactivity%20in%20IGF-IR%20null%20cells%20and%20suppression%20of%20downstream%20growth%20signaling%20using%20the%20dual%20IGF-IR%2FIR%20inhibitor%2C%20BMS-754807&journal=Endocrinology&volume=151&pages=4123-4132&publication_year=2010&author=Dinchuk%2CJE earning monthly?
- What's the total monthly financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23066310?
- What are the total earnings of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3468848?
- How much money does http://scholar.google.com/scholar_lookup?&title=KRAS%20mutation%20testing%20in%20metastatic%20colorectal%20cancer&journal=World%20J.%20Gastroenterol.&volume=18&pages=5171-5180&publication_year=2012&author=Tan%2CC&author=Du%2CX generate?
- What's the financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23792451?
- Revenue of http://scholar.google.com/scholar_lookup?&title=Discovery%20of%20colorectal%20cancer%20PIK3CA%20mutation%20as%20potential%20predictive%20biomarker%3A%20power%20and%20promise%20of%20molecular%20pathological%20epidemiology&journal=Oncogene&volume=33&pages=2949-2955&publication_year=2014&author=Ogino%2CS
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24042735 make?
- Learn how profitable http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3816225 is on a monthly basis
- How much income does http://scholar.google.com/scholar_lookup?&title=Epigenetic%20and%20genetic%20features%20of%2024%20colon%20cancer%20cell%20lines&journal=Oncogenesis&volume=2&publication_year=2013&author=Ahmed%2CD have?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20704563 make?
- How much does http://scholar.google.com/scholar_lookup?&title=Characterization%20of%20PF-4708671%2C%20a%20novel%20and%20highly%20specific%20inhibitor%20of%20p70%20ribosomal%20S6%20kinase%20%28S6K1%29&journal=Biochem.%20J.&volume=431&pages=245-255&publication_year=2010&author=Pearce%2CLR pull in?
- What's the total monthly financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21425998?
- What's the income generated by http://scholar.google.com/scholar_lookup?&title=Discovery%20of%20OSI-906%3A%20a%20selective%20and%20orally%20efficacious%20dual%20inhibitor%20of%20the%20IGF-1%20receptor%20and%20insulin%20receptor&journal=Future%20Med.%20Chem.&volume=1&pages=1153-1171&publication_year=2009&author=Mulvihill%2CMJ each month?
- How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24045180 make?
- http://scholar.google.com/scholar_lookup?&title=Overcoming%20IGF1R%2FIR%20resistance%20through%20inhibition%20of%20MEK%20signaling%20in%20colorectal%20cancer%20models&journal=Clin.%20Cancer%20Res.&volume=19&pages=6219-6229&publication_year=2013&author=Flanigan%2CSA's financial summary
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25818187's financial summary
- Get to know http://scholar.google.com/scholar_lookup?&title=The%20S6K%20protein%20family%20in%20health%20and%20disease&journal=Life%20Sci.&volume=131&pages=1-10&publication_year=2015&author=Tavares%2CMR's earnings
- What's the financial outcome of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11493700?
- Discover the revenue of http://scholar.google.com/scholar_lookup?&title=p70S6%20kinase%20signals%20cell%20survival%20as%20well%20as%20growth%2C%20inactivating%20the%20pro-apoptotic%20molecule%20BAD&journal=Proc.%20Natl%20Acad.%20Sci.%20USA&volume=98&pages=9666-9670&publication_year=2001&author=Harada%2CH&author=Andersen%2CJS&author=Mann%2CM&author=Terada%2CN&author=Korsmeyer%2CSJ
- How much does http://scholar.google.com/scholar_lookup?&title=Mechanisms%20of%20acquired%20resistance%20to%20insulin-like%20growth%20factor%201%20receptor%20inhibitor%20in%20MCF-7%20breast%20cancer%20cell%20line&journal=Investig.%20New%20Drugs&volume=31&pages=293-303&publication_year=2013&author=Ekyalongo%2CRC make?
- What's http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15082783's gross income?
- What's the total monthly financial gain of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC387765?
- What's http://scholar.google.com/scholar_lookup?&title=A%20novel%20function%20of%20the%20MA-3%20domains%20in%20transformation%20and%20translation%20suppressor%20Pdcd4%20is%20essential%20for%20its%20binding%20to%20eukaryotic%20translation%20initiation%20factor%204A&journal=Mol.%20Cell.%20Biol.&volume=24&pages=3894-3906&publication_year=2004&author=Yang%2CHS's gross income?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22431522 income
- See how much http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3347423 makes per month
- Get to know http://scholar.google.com/scholar_lookup?&title=Tumor%20suppressor%20PDCD4%20represses%20internal%20ribosome%20entry%20site-mediated%20translation%20of%20antiapoptotic%20proteins%20and%20is%20regulated%20by%20S6%20kinase%202&journal=Mol.%20Cell.%20Biol.&volume=32&pages=1818-1829&publication_year=2012&author=Liwak%2CU's earnings
- What are the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17053147?
- What's the income of http://scholar.google.com/scholar_lookup?&title=S6K1-%20and%20betaTRCP-mediated%20degradation%20of%20PDCD4%20promotes%20protein%20translation%20and%20cell%20growth&journal=Science&volume=314&pages=467-471&publication_year=2006&author=Dorrello%2CNV?
- Explore the financials of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21531565
- Get to know what's the income of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112285
- How much does http://scholar.google.com/scholar_lookup?&title=The%20Ras-ERK%20and%20PI3K-mTOR%20pathways%3A%20cross-talk%20and%20compensation&journal=Trends%20Biochem.%20Sci.&volume=36&pages=320-328&publication_year=2011&author=Mendoza%2CMC&author=Er%2CEE&author=Blenis%2CJ make?
- Check the income stats for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10576742
- What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=Phosphorylation%20and%20regulation%20of%20Raf%20by%20Akt%20%28protein%20kinase%20B%29&journal=Science&volume=286&pages=1741-1744&publication_year=1999&author=Zimmermann%2CS&author=Moelling%2CK?
- What's http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11782426's gross income?
- How profitable is http://www.ncbi.nlm.nih.gov/pmc/articles/PMC125807?
- How much money does http://scholar.google.com/scholar_lookup?&title=Regulation%20of%20Raf-1%20activation%20and%20signalling%20by%20dephosphorylation&journal=EMBO%20J.&volume=21&pages=64-71&publication_year=2002&author=Dhillon%2CAS&author=Meikle%2CS&author=Yazici%2CZ&author=Eulitz%2CM&author=Kolch%2CW make?
- Profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23185517
- What is the earnings of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3503708?
- What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=Anti-myeloma%20activity%20of%20Akt%20inhibition%20is%20linked%20to%20the%20activation%20status%20of%20PI3K%2FAkt%20and%20MEK%2FERK%20pathway&journal=PLoS%20ONE&volume=7&publication_year=2012&author=Ramakrishnan%2CV?
- What's the monthly money flow for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25843685?
- What's the profit of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4428983?
- What's the revenue for http://scholar.google.com/scholar_lookup?&title=p70%20S6-kinase%20mediates%20the%20cooperation%20between%20Akt1%20and%20Mek1%20pathways%20in%20fibroblast-mediated%20extracellular%20matrix%20remodeling&journal=Biochim.%20Biophys.%20Acta&volume=1853&pages=1626-1635&publication_year=2015&author=Goc%2CA&author=Sabbineni%2CH&author=Abdalla%2CM&author=Somanath%2CPR?
- How profitable is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=28632938?
- How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5579385 bring in each month?
- Revenue of http://scholar.google.com/scholar_lookup?&title=MEK%20inhibitors%20induce%20Akt%20activation%20and%20drug%20resistance%20by%20suppressing%20negative%20feedback%20ERK-mediated%20HER2%20phosphorylation%20at%20Thr701&journal=Mol.%20Oncol.&volume=11&pages=1273-1287&publication_year=2017&author=Chen%2CCH
- How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=28225038 generate?
- What is the monthly revenue of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5320536?
- How much profit does http://scholar.google.com/scholar_lookup?&title=Direct%20binding%20of%20MEK1%20and%20MEK2%20to%20AKT%20induces%20Foxo1%20phosphorylation%2C%20cellular%20migration%20and%20metastasis&journal=Sci.%20Rep.&volume=7&publication_year=2017&author=Procaccia%2CS&author=Ordan%2CM&author=Cohen%2CI&author=Bendetz-Nezer%2CS&author=Seger%2CR make?
- Find out how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22393466 earns monthly
- How much revenue does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278903 generate?
- How much money does http://scholar.google.com/scholar_lookup?&title=AKT%20activation%20by%20Pdcd4%20knockdown%20up-regulates%20cyclin%20D1%20expression%20and%20promotes%20cell%20proliferation&journal=Genes%20Cancer&volume=2&pages=818-828&publication_year=2011&author=Guo%2CX&author=Li%2CW&author=Wang%2CQ&author=Yang%2CHS make?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11846609 rake in every month?
- How much income does http://scholar.google.com/scholar_lookup?&title=Analysis%20of%20relative%20gene%20expression%20data%20using%20real-time%20quantitative%20PCR%20and%20the%202%28-Delta%20Delta%20C%28T%29%29%20method&journal=Methods&volume=25&pages=402-408&publication_year=2001&author=Livak%2CKJ&author=Schmittgen%2CTD have?
- What's the monthly income of https://citation-needed.springer.com/v2/references/10.1038/s41392-020-0204-0?format=refman&flavour=references?
- https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Qing%20Wang income
- Learn how profitable https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Qing%20Wang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en is on a monthly basis
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Yan%20Zhang gross monthly?
- Learn about the earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Yan%20Zhang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- How much money does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Jiang%20Zhu generate?
- How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Jiang%20Zhu%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en produce monthly?
- What's the monthly income of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Honggang%20Zheng?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Honggang%20Zheng%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en net monthly?
- How much profit is https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Shuntai%20Chen making per month?
- Learn about the earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Shuntai%20Chen%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- Financial intake of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Li%20Chen
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Li%20Chen%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en pull in monthly?
- What's https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Hsin-Sheng%20Yang's gross income?
- How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Hsin-Sheng%20Yang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en bring in?
- How much does https://static-content.springer.com/esm/art%3A10.1038%2Fs41392-020-0204-0/MediaObjects/41392_2020_204_MOESM1_ESM.pdf pull in?
- What's the income generated by http://creativecommons.org/licenses/by/4.0/ each month?
- Monthly income for https://s100.copyright.com/AppDispatchServlet?title=IGF-1R%20inhibition%20induces%20MEK%20phosphorylation%20to%20promote%20survival%20in%20colon%20carcinomas&author=Qing%20Wang%20et%20al&contentID=10.1038%2Fs41392-020-0204-0©right=The%20Author%28s%29&publication=2059-3635&publicationDate=2020-08-26&publisherName=SpringerNature&orderBeanReset=true&oa=CC%20BY
- How much income is https://crossmark.crossref.org/dialog/?doi=10.1038/s41392-020-0204-0 earning monthly?
- How much does https://citation-needed.springer.com/v2/references/10.1038/s41392-020-0204-0?format=refman&flavour=citation pull in?
- Discover the revenue of https://doi.org/10.1186/s13071-024-06273-x
- What is the earnings of https://doi.org/10.1186/s12951-024-02983-7?
- Revenue of https://doi.org/10.1007/s12094-024-03492-7
- Discover the revenue of https://doi.org/10.1186/s12885-022-09961-y
- What's https://doi.org/10.1038/s41419-021-03833-2's gross income?
- Monthly income for https://www.protocols.io/
- Get to know what's the income of https://www.natureindex.com/
- See how much http://www.naturechina.com makes per month
- How much cash flow does https://www.natureasia.com/ja-jp have monthly?
Analytics and Tracking {📊}
- Google Tag Manager
Libraries {📚}
- Prism.js
- Zoom.js
Emails and Hosting {✉️}
Mail Servers:
- mxa-002c5801.gslb.pphosted.com
- mxb-002c5801.gslb.pphosted.com
Name Servers:
- pdns1.ultradns.net
- pdns2.ultradns.net
- pdns3.ultradns.org
- pdns4.ultradns.org
- pdns5.ultradns.info
- pdns6.ultradns.co.uk
CDN Services {📦}
- Crossref